Pharmacogenetic correlates of clinical benefit from gemcitabine and platinum in patients with advanced bladder cancer

M. Castro,A Neumann,M. Konichezky,K. Danenberg,S. Stemmer

Pharmacogenetic correlates of clinical benefit from gemcitabine and platinum in patients with advanced bladder cancer

2004

M. Castro
A Neumann
M. Konichezky
K. Danenberg
S. Stemmer

3202 Background: The expression level of the DNA excision repair gene ERCC1 has been correlated with outcome in pts receiving platinum agents for a variety of malignancies. While ribonucleotide red...

Keywords:

Pathology
Pharmacogenetics
Cancer research
Gemcitabine
Bladder cancer
Oncology
Internal medicine
Medicine
Ribonucleotide
ERCC1
in patient
Platinum
DNA excision
advanced bladder cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations